Search Results - "Budinger, M D"

Intravenous immune globulin for prevention of cytomegalovirus infection and interstitial pneumonia after bone marrow transplantation by Winston, D J, Ho, W G, Lin, C H, Bartoni, K, Budinger, M D, Gale, R P, Champlin, R E

“…The effects of high doses of polyvalent intravenous immune globulin given for prophylaxis of cytomegalovirus infection and interstitial pneumonia in recipients…”
Get more information

Intravenous immunoglobulin for modification of cytomegalovirus infections associated with bone marrow transplantation. Preliminary results of a controlled trial by Winston, D J, Ho, W G, Lin, C H, Budinger, M D, Champlin, R E, Gale, R P

“…The effects of immune globulin intravenous, 5 percent in 10 percent maltose, on cytomegalovirus infection and interstitial pneumonia in bone marrow transplants…”
Get more information

Comparison of varicella zoster antibody titers in patients given intravenous immune serum globulin or varicella zoster immune globulin by Paryani, S G, Arvin, A M, Koropchak, C M, Dobkin, M B, Wittek, A E, Amylon, M D, Budinger, M D

“…We compared the VZV IgG antibody titers after administration of varicella zoster immune globulin and serum immune globulin intravenously (IGIV) in VZV…”
Get more information

Transmission of hepatitis after the administration of intravenous immunoglobulins by Rousell, R H, Dobkin, M B, Budinger, M D, Louie, R E

Get more information

Comparison of high-dose and low-dose intravenous immunoglobulin therapy in patients with primary immunodeficiency diseases by Ochs, H D, Fischer, S H, Wedgwood, R J, Wara, D W, Cowan, M J, Ammann, A J, Saxon, A, Budinger, M D, Allred, R U, Rousell, R H

“…To assess safety and efficacy of high-dose intravenous immunoglobulin therapy in patients with primary immunodeficiency syndromes we treated a group of 19…”
Get more information

Immunomodulatory and Antimicrobial Efficacy of Intravenous Immunoglobulin in Bone Marrow Transplantation by Sullivan, Keith M, Kopecky, Kenneth J, Jocom, Jane, Fisher, Lyly, Buckner, C. Dean, Meyers, Joel D, Counts, George W, Bowden, Raleigh A, Petersen, Finn Bo, Witherspoon, Robert P, Budinger, Miriam D, Schwartz, Richard S, Appelbaum, Frederick R, Clift, Reginald A, Hansen, John A, Sanders, Jean E, Thomas, E. Donnall, Storb, Rainer

“…IMMUNODEFICIENCY following myeloablative chemoradiotherapy can foster a variety of opportunistic infections after bone marrow transplantation. 1 2 3 4…”
Get full text

Prospective study on the hepatitis safety of intravenous immunoglobulin, pH 4.25 by Rousell, R H, Budinger, M D, Pirofsky, B, Schiff, R I

“…Recent reports of transmission by intravenous gamma-globulin preparations of non-A non-B hepatitis (NANBH), including several cases that progressed to severe…”
Get more information

Anticomplementary activity and the safety of intravenous immunoglobulin by Rousell, R H, Budinger, M D, Keppler, D C, Victor, R, Minaga, T

“…Quality assurance release levels for anti-complementary (AC) activity of a non-modified intravenous immunoglobulin (IGIV, pH 4.25) were reviewed over a period…”
Get more information

Varicella zoster antibody titers after the administration of intravenous immune serum globulin or varicella zoster immune globulin by Paryani, S G, Arvin, A M, Koropchak, C M, Wittek, A E, Amylon, M D, Dobkin, M B, Budinger, M D

“…Varicella is a serious infection in the immunocompromised patient. Prophylaxis with varicella zoster immune globulin is known to decrease the incidence of…”
Get more information

Trend in Clinical Trial Participation During COVID-19: A Secondary Analysis of the I-SPY COVID Clinical Trial by Yang, Philip, Dickert, Neal W, Haczku, Angela, Spainhour, Christine, Auld, Sara C

“…To analyze the temporal trend in enrollment rates in a COVID-19 platform trial during the first three waves of the pandemic in the United States. Secondary…”
Get full text

Humoral Human Lung Allograft Rejection by Tissue-Restricted Non-HLA Antibodies by Fernandez, Ramiro, MD, Chiu, Stephen, MD, Raparia, Kirtee, MD, Garcha, Puneet, MD, Farver, Carol, MD, Budev, Marie, MD, Tambur, Anat R., PhD, DeCamp, Malcolm M., MD, Budinger, Scott, MD, Perlman, Harris, MD, Mohanakumar, T., PhD, Bharat, Ankit, MD

“…A third of lung recipients have preexisting antibodies against nonhuman leukocyte self-antigens (nHAbs) present in the lung tissue. These nHAbs also form de…”
Get full text

Use of a New, Low-pH Immunoglobulin G Preparation during Episodes of Bacteremia in the Rat by Thomas E. Emerson, Jr, Collins, Michael S., Miriam D. Budinger

“…A rapidly expanding role for immunoglobulin G preparations in conditions other than the classical immunodeficiency syndromes is evident. This relatively new…”
Get full text

The cardiomyocyte protein αT-catenin contributes to asthma through regulating pulmonary vein inflammation by Folmsbee, Stephen Sai, Budinger, G.R. Scott, MD, Bryce, Paul J., PhD, Gottardi, Cara J., PhD

“…Background Recent genome-wide association studies have identified single nucleotide polymorphisms in the gene encoding the protein αT-catenin (CTNNA3) that…”
Get full text

β2 -Agonist therapy may contribute to the air pollution and IL-6–associated risk of developing severe asthma with dual-positive TH 2/TH 17 cells by Chiarella, Sergio E., MD, Budinger, G.R. Scott, MD, Mutlu, Gökhan M., MD

Get full text

Defining the Cell Type through Which the Asthma-Associated Intercellular Junction Protein Alpha-T-Catenin Drives Asthma Phenotypes in Mice by Chiarella, Sergio E., MD, Gonzalez-Gonzalez, Francisco J., MD, McQuattie-Pimentel, Alexandra C., MD, Singer, Benjamin D., MD, Budinger, G.R. Scott, MD, Schleimer, Robert P., PhD, FAAAAI, Gottardi, Cara J., PhD

“…Rationale We recently showed that the genetic loss of aT-catenin (aT-cat) in mice attenuated house dust mite-induced airway inflammation and…”
Get full text

Use of a polyvalent intravenous immunoglobulin or specific cytomegalovirus hyperimmunoglobulin for modification of cytomegalovirus infections and prevention of interstitial pneumonias following bone marrow transplantation by Winston, D J, Ho, W G, Lin, G H, Bartoni, K, Budinger, M D, Gale, R P, Champlin, R E

“…The effects of prophylactic, polyvalent intravenous immune globulin on cytomegalovirus infection and interstitial pneumonia in allogenic marrow transplants…”
Get more information